Table 1.
Demographics and Serum Level Comparisons Between Patients and Controls.
| Patients (n=14) | Controls (n=14) | P value | |
|---|---|---|---|
| Age (years) | 70.79 ± 4.71 | 68.69 ± 5.69 | 0.327 |
| Body mass index (Kg/m2) | 26.26 ± 4.34 | 26.94 ± 2.93 | 0.589 |
| Total testosterone (ng/dL) | 476.88 ± 169.68 | 514.06 ± 174.12 | 0.360 |
| Free testosterone (ng/dL) | 7.99 ± 2.40 | 7.52 ± 2.79 | 0.493 |
| Bioavailable testosterone (ng/dL) | 187.21 ± 56.36 | 176.40 ± 65.37 | 0.492 |
| Luteinizing hormone (U/L) | 5.27 ± 2.74 | 5.97 ± 2.57 | 0.454 |
| Follicle stimulating hormone (U/L) | 7.42 ± 4.27 | 9.16 ± 5.86 | 0.406 |
| Estradiol-17 beta (pg/mL) | 41.03 ± 11.91 | 43.12 ± 10.54 | 0.771 |
| Sex-hormone binding globulin (nmol/L) | 46.83 ± 16.36 | 59.81 ± 24.75 | 0.158 |
| Prolactin (ng/mL) | 5.41 ± 1.89 | 6.97 ± 3.13 | 0.190 |
| Aspartate aminotransferase (U/L) | 25.14 ± 5.78 | 28.56 ± 10.55 | 0.287 |
| Alanine aminotransferase (U/L) | 29.14 ± 17.97 | 29.62 ± 19.48 | 0.819 |
| Creatinine (mg/dL) | 1.25 ± 0.17 | 1.13 ± 0.11 | 0.050 |
| Free thyroxine (ng/dL) | 1.24 ± 0.22 | 1.25 ± 0.12 | 0.245 |
| Thyroid-stimulating hormone (mIU/L) | 1.51 ± 0.58 | 1.55 ± 1.50 | 0.258 |